Investigating the link between FGF23 and heart rhythm issues in dialysis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between fibroblast growth factor 23 (FGF23) levels and cardiac arrhythmias in patients undergoing maintenance hemodialysis. By monitoring changes in FGF23 during dialysis and their association with electrocardiographic abnormalities, particularly QTc prolongation, the study seeks to enhance understanding of the mechanisms that may lead to heart rhythm disturbances in chronic kidney disease patients. The research will be conducted at a single center, focusing on a well-characterized group of hemodialysis patients over a defined period.

Why it matters

Who can join: the full rules

The study envisages the enrolment of:

* Adult subjects (\>18 years of age) who can sign an informed consent.
* on maintenance HD (for at least 3 months)

Exclusion Criteria:

* history of cardiac arrhythmias at study recruitment define as atrial fibrillation or pace-maker assisted cardiac rhythm

Where it's running

• Servizio di Nefrologia, Ospedale Regionale di Lugano, Civico
  Lugano, Switzerland Recruiting

Study contacts

• Principal investigator: Antonio Bellasi, MD, PhD — Ente Ospedaliero Cantonale, Bellinzona
• Study coordinator: Antonio Bellasi, MD, PhD
• Email: antonio.bellasi@eoc.ch
• Phone: +410918117119

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Bioimpedance Spectroscopy for Fluid Changes in Hemodialysis Patients

  This study tests whether raw bioimpedance data can help doctors gauge fluid changes in people on hemodialysis and guides fluid removal decisions.

  Recruiting University of Aarhus · Aarhus, Central Denmark · NCT07803029

• Nurse-led dialysis self-management program for distress in adults on hemodialysis

  A nurse-led program helps adults on hemodialysis see if structured self-management support reduces dialysis-related distress compared to routine care.

  Recruiting Kutahya Health Sciences University · Simav · NCT07747012

• Repeated brief limb ischemia to see its effect on blood pressure and inflammation in people with kidney disease

  This study tests whether short, repeated episodes of limb ischemia can influence blood pressure, heart rate, and inflammation in adults with chronic kidney disease who may be on hemodialysis.

  Recruiting at 2 sites Medical University of Lodz · Lodz and 1 other locations · NCT07746102

• Mindfulness Meditation for Hemodialysis Patients

  A small trial tests whether a 4-week mindfulness meditation program in addition to usual care can improve sleep quality and reduce stress and symptoms in adults on hemodialysis.

  Recruiting at 4 sites Cyprus Aydin University · Famagusta and 3 other locations · NCT07620990

• Progressive muscle relaxation to ease depression and fatigue during hemodialysis

  This trial will try whether guided progressive muscle relaxation can reduce depression and fatigue in people receiving hemodialysis.

  Recruiting at 2 sites Istanbul Aydın University · Istanbul, Istanbul and 1 other locations · NCT07512895

• Multispecies synbiotic in people on hemodialysis

  This pilot study tests whether a multispecies synbiotic can alter gut microbes and reduce gut-derived toxins in adults on maintenance hemodialysis over 12 weeks.

  Recruiting Tungs' Taichung Metroharbour Hospital · Taichung, Wuqi District · NCT07461233

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.